Literature DB >> 6778340

Mucosal immune system: implications in otitis media with effusion.

J M Bernstein, P L Ogra.   

Abstract

The ontogeny of the mucosal immune system as it relates to the development of lymphoid tissue in the respiratory tract and the gastrointestinal tract has been studied quite extensively over the past few years. It is apparent now that the bronchus-associated lymphoid tissue and gut-associated lymphoid tissue are the major sources of immunocompetent precursor B lymphocytes. After the induction of antigens in the respiratory tract or the gastrointestinal tract, precursor lymphoid cells in these sites are preferentially activated to undergo significant proliferation. Such antigen-sensitized cells eventually migrate to other mucosa sites, such as mammary glands, genital tract, conjuctiva, etc. Recent evidence has suggested that the immunocompetent tissue observed in the middle ear cleft during otitis media with effusion may function as an extension of the mucosal immune system in the upper respiratory tract. The implications of these observations relative to middle ear disease are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6778340     DOI: 10.1177/00034894800890s378

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol Suppl        ISSN: 0096-8056


  3 in total

1.  Expression of cytokine genes during pneumococcal and nontypeable Haemophilus influenzae acute otitis media in the rat.

Authors:  A Melhus; A F Ryan
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  An immunological study of otitis media with effusion. Antibodies directed against coagulase-negative staphylococci in the effusion fluid.

Authors:  T Bunse; H Hildmann; W Zan; W Opferkuch
Journal:  Arch Otorhinolaryngol       Date:  1987

3.  Differential expression of cytokine genes and inducible nitric oxide synthase induced by opacity phenotype variants of Streptococcus pneumoniae during acute otitis media in the rat.

Authors:  J P Long; H H Tong; P A Shannon; T F DeMaria
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.